+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Flow Cytometry Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (Asia Pacific)

  • PDF Icon

    Report

  • 331 Pages
  • September 2024
  • Region: Asia Pacific
  • Fairfield Market Research
  • ID: 6003917
The flow cytometry market in the Asia Pacific region is on the verge of significant expansion, driven by technological advancements and a growing demand across various sectors. In 2024, the market size is projected to reach USD 899.8 million, with a forecasted expansion to USD 1.28 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.30%. This market, which involves the use of flow cytometers for immunophenotyping, diagnostics, and research, is expected to see substantial growth in the coming years.

Market Overview

Flow cytometry, a technique that enables the rapid and detailed analysis of individual cells in a liquid medium, is gaining traction throughout Asia Pacific. By utilizing lasers to produce scattered and fluorescent light signals, flow cytometers deliver crucial insights into immune cell counts, cell cycle phases, cancer cell detection, and molecular interactions. This capability has made flow cytometry a vital tool in both medical diagnostics and research.

Market Growth and Projections

The Asia Pacific flow cytometry market is experiencing strong growth, with forecasts indicating a significant rise in market value. This growth is fueled by advancements in technology and a broader adoption across different sectors. The region's market, which has consistently expanded, is anticipated to maintain this positive trend.

Impact of COVID-19

The COVID-19 pandemic has notably affected the flow cytometry market in Asia Pacific. The pandemic underscored the limitations of traditional testing methods such as PCR and antibody tests, leading to an increased demand for flow cytometry. This technique's precision and high-throughput testing capabilities proved invaluable during the pandemic. The surge in demand has driven manufacturers to innovate and develop advanced systems, further boosting market growth.

Technological Advancements

Recent technological advancements in flow cytometry have been a major driver of market expansion. Innovations such as high-throughput flow cytometry and advanced systems that offer enhanced efficacy have significantly improved the utility of flow cytometry. These advancements have solidified flow cytometry's position as a preferred tool for researchers and clinicians.

Market Dynamics

Rising Demand for Healthcare Services

The demand for flow cytometers is increasing due to the growing need for high-quality healthcare services in ASEAN economies. Flow cytometry has become a routine tool for clinical pathologists and immunologists, widely used for diagnosing and monitoring cancer and immunological disorders. The emergence of high-throughput flow cytometry has further augmented its utility by enabling the simultaneous analysis of multiple samples.

Adoption Challenges

Despite the positive outlook, high capital expenditure for acquiring and maintaining advanced flow cytometers remains a significant challenge. The substantial costs associated with these sophisticated devices, along with maintenance fees, can be a financial burden for some institutions, particularly in emerging nations, limiting their ability to fully utilize flow cytometry equipment.

Regional Insights

Australia

Australia is emerging as a key market for flow cytometers, supported by increasing government investment in diagnostic research and development. The country’s strong commitment to advancing research and development, bolstered by substantial investments from both the government and private sector, continues to drive growth in the flow cytometry market.

South Korea

South Korea is making significant advancements in flow cytometry, focusing on high-content screening and multiparameter analysis. These developments have enhanced the ability to conduct comprehensive investigations of complex biological systems, contributing to the region's notable market share.

Indonesia

In Indonesia, the rising prevalence of chronic and infectious diseases is driving the demand for flow cytometers. Healthcare practitioners in the country are increasingly using flow cytometry for real-time analysis of cellular composition and immunological pathways. Despite challenges related to organizing and funding R&D initiatives, the demand for flow cytometry technology continues to grow.

Segment Analysis

Consumables

In the Asia Pacific flow cytometry market, consumables, including reagents and accessories, hold a significant share. These products are crucial for various assays and are extensively used in flow cytometry applications, driving their high demand.

Applications

Immunophenotyping is a prominent application of flow cytometry. This technique is widely used for evaluating cell types and detecting deviations in antigen production. Its efficiency in characterizing different cell types makes it a critical component of flow cytometry applications.

Research Applications

Flow cytometry plays a crucial role in research, with a significant portion of its applications dedicated to research purposes. The technology's ability to perform detailed analyses and investigations, especially in stem cell research and clinical studies, highlights its importance in the research community.

Competitive Analysis

  • Beckman Coulter
  • Becton Dickinson & Co.
  • Life Technologies Corporation (Thermo Fisher Scientific Inc.)
  • Miltenyi Biotec
  • Luminex Corp.
  • Merck KGaA
  • bioMérieux SA
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Apogee Flow Systems Ltd.
  • Stratedigm, Inc.
  • Sysmex Partec
  • Sony Biotechnology
  • Cytek® Biosciences
  • Sartorius AG
  • Hamamatsu Photonics K.K
  • FURUKAWA ELECTRIC CO., LTD
  • Accellix
  • Shenzhen Mindray BioMedical Electronics Co., Ltd

Asia Pacific Flow Cytometry Industry Segmentation

Product:

  • Flow Cytometer Systems
  • Traditional Flow Cytometers
  • Cell Sorters
  • Imaging Flow Cytometers
  • Acoustic Focusing Cytometers
  • Next-generation Flow Cytometers
  • Reagents, Consumables, & Accessories
  • Software
  • Services

Application:

  • Immunophenotyping
  • Cell Sorting
  • Cell Cycle Analysis
  • Apoptosis
  • Cell Proliferation Assays
  • Intracellular Calcium Flux
  • Detection & Sorting of Exosomes
  • Others

Usage:

  • Research Use
  • Clinical Diagnostics

End User:

  • Hospitals
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Biopharmaceutical Companies

Country:

  • South Korea
  • Hong Kong
  • Taiwan
  • Australia
  • New Zealand
  • Indonesia
  • Thailand
  • Malaysia
  • Vietnam
  • Singapore
  • Philippines


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Asia Pacific Flow Cytometry Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Price Analysis, 2019 - 2023
3.1. Global Average Price Analysis, by Product Type, US$ Per Unit, 2019 - 2023
3.2. Prominent Factor Affecting Multilayer Ceramic Capacitors Prices
3.3. Global Average Price Analysis, by Region, US$ Per Unit
4. Asia Pacific Flow Cytometry Market Outlook, 2019 - 2031
4.1. Asia Pacific Flow Cytometry Market Outlook, by Product Type, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.1.1. Key Highlights
4.1.1.1. Flow Cytometer Systems
4.1.1.1.1. Traditional Flow Cytometers
4.1.1.1.1.1. Cell Sorters
4.1.1.1.1.2. Imaging Flow Cytometers
4.1.1.1.2. Acoustic Focusing Cytometers
4.1.1.1.3. Next-generation Flow Cytometers
4.1.1.2. Reagents, Consumables, & Accessories
4.1.1.3. Software
4.1.1.4. Services
4.2. Asia Pacific Flow Cytometry Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.2.1. Key Highlights
4.2.1.1. Immunophenotyping
4.2.1.2. Cell Sorting
4.2.1.3. Cell Cycle Analysis
4.2.1.3.1. Apoptosis
4.2.1.3.2. Cell Proliferation Assays
4.2.1.3.3. Intracellular Calcium Flux
4.2.1.4. Detection & Sorting of Exosomes
4.2.1.5. Others
4.3. Asia Pacific Flow Cytometry Market Outlook, by Usage, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.3.1. Key Highlights
4.3.1.1. Research Use
4.3.1.2. Clinical Diagnostics
4.4. Asia Pacific Flow Cytometry Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.4.1. Key Highlights
4.4.1.1. Hospitals
4.4.1.2. Diagnostic Laboratories
4.4.1.3. Academic & Research Institutes
4.4.1.4. Biopharmaceutical Companies
4.5. Asia Pacific Multilayer Ceramic Capacitors Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1. Key Highlights
4.5.1.1. China Multilayer Ceramic Capacitors Market by Product Type, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.2. China Multilayer Ceramic Capacitors Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.3. China Multilayer Ceramic Capacitors Market by Usage, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.4. China Multilayer Ceramic Capacitors Market by End User, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.5. Japan Multilayer Ceramic Capacitors Market by Product Type, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.6. Japan Multilayer Ceramic Capacitors Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.7. Japan Multilayer Ceramic Capacitors Market by Usage, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.8. Japan Multilayer Ceramic Capacitors Market by End User, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.9. South Korea Multilayer Ceramic Capacitors Market by Product Type, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.10. South Korea Multilayer Ceramic Capacitors Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.11. South Korea Multilayer Ceramic Capacitors Market by Usage, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.12. South Korea Multilayer Ceramic Capacitors Market by End User, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.13. India Multilayer Ceramic Capacitors Market by Product Type, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.14. India Multilayer Ceramic Capacitors Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.15. India Multilayer Ceramic Capacitors Market by Usage, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.16. India Multilayer Ceramic Capacitors Market by End User, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.17. Southeast Asia Multilayer Ceramic Capacitors Market by Product Type, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.18. Southeast Asia Multilayer Ceramic Capacitors Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.19. Southeast Asia Multilayer Ceramic Capacitors Market by Usage, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.20. Southeast Asia Multilayer Ceramic Capacitors Market by End User, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.21. Rest of Asia Pacific Multilayer Ceramic Capacitors Market by Product Type, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.22. Rest of Asia Pacific Multilayer Ceramic Capacitors Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.23. Rest of Asia Pacific Multilayer Ceramic Capacitors Market by Usage, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.24. Rest of Asia Pacific Multilayer Ceramic Capacitors Market by End User, Value (US$ Mn) and Volume (Units), 2019 - 2031
5. Competitive Landscape
5.1. Product Type vs Application Heatmap
5.2. Company Market Share Analysis, 2023
5.3. Competitive Dashboard
5.4. Company Profiles
5.4.1. Beckman Coulter
5.4.1.1. Company Overview
5.4.1.2. Product Portfolio
5.4.1.3. Financial Overview
5.4.1.4. Business Strategies and Development
5.4.2. Becton Dickinson & Co.
5.4.2.1. Company Overview
5.4.2.2. Product Portfolio
5.4.2.3. Financial Overview
5.4.2.4. Business Strategies and Development
5.4.3. Life Technologies Corporation (Thermo Fisher Scientific Inc.)
5.4.3.1. Company Overview
5.4.3.2. Product Portfolio
5.4.3.3. Financial Overview
5.4.3.4. Business Strategies and Development
5.4.4. Miltenyi Biotec
5.4.4.1. Company Overview
5.4.4.2. Product Portfolio
5.4.4.3. Financial Overview
5.4.4.4. Business Strategies and Development
5.4.5. Luminex Corp.
5.4.5.1. Company Overview
5.4.5.2. Product Portfolio
5.4.5.3. Financial Overview
5.4.5.4. Business Strategies and Development
5.4.6. Merck KGaA
5.4.6.1. Company Overview
5.4.6.2. Product Portfolio
5.4.6.3. Financial Overview
5.4.6.4. Business Strategies and Development
5.4.7. bioMérieux SA
5.4.7.1. Company Overview
5.4.7.2. Product Portfolio
5.4.7.3. Financial Overview
5.4.7.4. Business Strategies and Development
5.4.8. Agilent Technologies
5.4.8.1. Company Overview
5.4.8.2. Product Portfolio
5.4.8.3. Financial Overview
5.4.8.4. Business Strategies and Development
5.4.9. Bio-Rad Laboratories
5.4.9.1. Company Overview
5.4.9.2. Product Portfolio
5.4.9.3. Financial Overview
5.4.9.4. Business Strategies and Development
5.4.10. Apogee Flow Systems Ltd.
5.4.10.1. Company Overview
5.4.10.2. Product Portfolio
5.4.10.3. Financial Overview
5.4.10.4. Business Strategies and Development
5.4.11. Stratedigm, Inc.
5.4.11.1. Company Overview
5.4.11.2. Product Portfolio
5.4.11.3. Financial Overview
5.4.11.4. Business Strategies and Development
5.4.12. Sysmex Partec
5.4.12.1. Company Overview
5.4.12.2. Product Portfolio
5.4.12.3. Financial Overview
5.4.12.4. Business Strategies and Development
5.4.13. Sony Biotechnology
5.4.13.1. Company Overview
5.4.13.2. Product Portfolio
5.4.13.3. Financial Overview
5.4.13.4. Business Strategies and Development
5.4.14. Cytek® Biosciences
5.4.14.1. Company Overview
5.4.14.2. Product Portfolio
5.4.14.3. Financial Overview
5.4.14.4. Business Strategies and Development
5.4.15. Sartorius AG
5.4.15.1. Company Overview
5.4.15.2. Product Portfolio
5.4.15.3. Financial Overview
5.4.15.4. Business Strategies and Development
5.4.16. Hamamatsu Photonics K.K
5.4.16.1. Company Overview
5.4.16.2. Product Portfolio
5.4.16.3. Financial Overview
5.4.16.4. Business Strategies and Development
5.4.17. FURUKAWA ELECTRIC CO., LTD
5.4.17.1. Company Overview
5.4.17.2. Product Portfolio
5.4.17.3. Financial Overview
5.4.17.4. Business Strategies and Development
5.4.18. Accellix
5.4.18.1. Company Overview
5.4.18.2. Product Portfolio
5.4.18.3. Financial Overview
5.4.18.4. Business Strategies and Development
5.4.19. Shenzhen Mindray BioMedical Electronics Co., Ltd
5.4.19.1. Company Overview
5.4.19.2. Product Portfolio
5.4.19.3. Financial Overview
5.4.19.4. Business Strategies and Development
6. Appendix
6.1. Research Methodology
6.2. Report Assumptions
6.3. Acronyms and Abbreviations

Companies Mentioned

  • Beckman Coulter
  • Becton Dickinson & Co.
  • Life Technologies Corporation (Thermo Fisher Scientific Inc.)
  • Miltenyi Biotec
  • Luminex Corp.
  • Merck KGaA
  • bioMérieux SA
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Apogee Flow Systems Ltd.
  • Stratedigm, Inc.
  • Sysmex Partec
  • Sony Biotechnology
  • Cytek® Biosciences
  • Sartorius AG
  • Hamamatsu Photonics K.K
  • FURUKAWA ELECTRIC CO., LTD
  • Accellix
  • Shenzhen Mindray BioMedical Electronics Co., Ltd

Methodology

Loading
LOADING...